Dividend Worth Mentioning: Core Laboratories N.V. (NYSE:CLB) expects Nov 22, 2016 to be an important day for investors.

Dividend Worth Mentioning: Core Laboratories N.V. (NYSE:CLB) expects Nov 22, 2016 to be an important day for investors.

Core Laboratories N.V. (NYSE:CLB) is expected to pay $0.55 on Nov 22, 2016. The indicated annual dividend is $2.20. Shareholders owning the stock before Oct 19, 2016 will be eligible to receive the payout. Based on Core Laboratories N.V.’s current price of $110.59, the dividend is 0.50%. This dividend’s record date is Oct 21, 2016 and the announcement date is Oct 12, 2016. The stock decreased 0.74% or $0.82 on October 17, hitting $110.59. Core Laboratories N.V. (NYSE:CLB) has risen 0.65% since March 15, 2016 and is uptrending. It has underperformed by 4.84% the S&P500.

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the gas and oil industry. The company has a market cap of $4.82 billion. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase gas and oil recovery from their producing fields. It has a 58.72 P/E ratio. The Firm has over 70 offices in over 50 countries.

Insitutional Activity: The institutional sentiment increased to 1.09 in Q2 2016. Its up 0.10, from 0.99 in 2016Q1. The ratio increased, as 37 funds sold all Core Laboratories N.V. shares owned while 118 reduced positions. 53 funds bought stakes while 116 increased positions. They now own 43.11 million shares or 0.25% more from 43.00 million shares in 2016Q1.
Snyder Capital Management Ltd Partnership, a California-based fund reported 20,916 shares. Regions Fincl holds 0.04% or 23,659 shares in its portfolio. Mu Invests holds 950 shares or 0.08% of its portfolio. Motley Fool Wealth Management Ltd Liability Company holds 31,704 shares or 0.43% of its portfolio. Mechanics Bank & Trust Department accumulated 0.16% or 3,500 shares. Envestnet Asset Mngmt accumulated 120,251 shares or 0.06% of the stock. Blackrock Institutional Co Na accumulated 0.02% or 798,509 shares. Sumitomo Mitsui Asset Ltd has 3,018 shares for 0.01% of their US portfolio. Swiss National Bank has 118,800 shares for 0.02% of their US portfolio. Penbrook Mgmt Limited Liability Corporation, a New York-based fund reported 11,488 shares. Brown Brothers Harriman & Co holds 0% or 2,482 shares in its portfolio. Deutsche Comml Bank Ag has 0.06% invested in the company for 656,038 shares. Johnson Invest Counsel, a Ohio-based fund reported 1,673 shares. Banced last reported 2,802 shares in the company. Granahan Inv Inc Ma last reported 115,300 shares in the company.

Core Laboratories N.V. (NYSE:CLB) Ratings Coverage

Out of 15 analysts covering Core Laboratories (NYSE:CLB), 8 rate it a “Buy”, 0 “Sell”, while 7 “Hold”. This means 53% are positive. $155 is the highest target while $80 is the lowest. The $114.33 average target is 3.38% above today’s ($110.59) stock price. Core Laboratories has been the topic of 27 analyst reports since August 24, 2015 according to StockzIntelligence Inc. The company was maintained on Wednesday, September 30 by Sterne Agee CRT. Citigroup maintained it with “Neutral” rating and $110 target price in Wednesday, September 28 report. The rating was initiated by JP Morgan on Friday, June 10 with “Overweight”. On Monday, May 16 the stock rating was maintained by Citigroup with “Neutral”. Howard Weil maintained it with “Sector Perform” rating and $105 target price in Friday, January 29 report. On Thursday, October 6 the stock rating was initiated by DA Davidson with “Buy”. The rating was maintained by Morgan Stanley on Tuesday, April 19 with “Overweight”. The rating was initiated by Oppenheimer with “Perform” on Tuesday, January 12. The stock of Core Laboratories N.V. (NYSE:CLB) has “Outperform” rating given on Friday, October 23 by RBC Capital Markets. As per Thursday, September 1, the company rating was initiated by Credit Suisse.

More notable recent Core Laboratories N.V. (NYSE:CLB) news were published by: Zacks.com which released: “Core Laboratories (CLB) Q3 Earnings: Stock to Disappoint?” on October 17, 2016, also Fool.com with their article: “Core Laboratories NV Earnings Bottom Out” published on July 21, 2016, Prnewswire.com published: “Core Laboratories’ Third Quarter 2016 Webcast At 7:30 A.M. CDT / 2:30 P.M …” on October 04, 2016. More interesting news about Core Laboratories N.V. (NYSE:CLB) were released by: Fool.com and their article: “Core Laboratories N.V. Earnings Hit by the Rig Count Slide” published on April 21, 2016 as well as Fool.com‘s news article titled: “What’s Core Laboratories N.V. Doing to Outperform Its Oil-Service Peers?” with publication date: November 08, 2015.

CLB Company Profile

Core Laboratories N.V., incorporated on July 8, 1994, is a well-known provider of reservoir description, production enhancement and reservoir management services to the gas and oil industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase gas and oil recovery from their producing fields. The Firm has over 70 offices in over 50 countries. The Firm operates in three divisions: Reservoir Description, Production Enhancement and Reservoir Management. These divisions provide different services and products and utilize different technologies for improving reservoir performance, and increasing gas and oil recovery from new and existing fields. The Firm offers its services through its global network of offices. The Firm makes products primarily in over four facilities for distribution on a global basis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment